News & Updates

Lebrikizumab improves anxiety, depression symptoms in adolescents with AD

18 Mar 2025 by

Lebrikizumab improves anxiety and depression symptoms, as shown by PROMIS* scores, in patients with moderate-to-severe atopic dermatitis (AD), according to the ADore trial presented at AAAAI/WAO 2025.

Lebrikizumab improves anxiety, depression symptoms in adolescents with AD

18 Mar 2025

Children with food allergies at risk of stunting, but immunotherapy helps

16 Mar 2025 by

Eliminating certain foods such as egg and milk from children’s diet due to IgE-mediated allergy may hinder growth, but oral immunotherapy helps improve growth trajectories, especially when initiated at a younger age, according to two studies.

Children with food allergies at risk of stunting, but immunotherapy helps

16 Mar 2025

Could early formula feeding be promoting infant food allergies?

15 Mar 2025 by

Newborns who are not exclusively fed colostrum within the first 3 days of life may have a higher likelihood of developing food allergies, according to a study.

Could early formula feeding be promoting infant food allergies?

15 Mar 2025

Ruxolitinib cream shows benefit in patients with AD regardless of age

15 Mar 2025 by

Twice-daily application of ruxolitinib cream appears effective and well tolerated in the treatment of mild-to-moderate atopic dermatitis (AD) regardless of age, based on a pooled analysis of three phase III trials presented at AAAAI/WAO 2025.

Ruxolitinib cream shows benefit in patients with AD regardless of age

15 Mar 2025

Original New Drug Application Approvals by US FDA (16-28 February 2025)

14 Mar 2025

New drug applications approved by US FDA as of 16-28 February 2025 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Original New Drug Application Approvals by US FDA (16-28 February 2025)

14 Mar 2025

SG sees drop in paediatric pneumococcal disease burden

13 Mar 2025 by

The introduction of pneumococcal conjugate vaccines (PCV) into Singapore's National Childhood Immunisation Schedule (NCIS) has reduced the incidence of invasive pneumococcal disease (IPD) in children by nearly a third, as reported in a study.

SG sees drop in paediatric pneumococcal disease burden

13 Mar 2025

COVID-19 may leave lingering GI issues in children

10 Mar 2025 by

In children and adolescents who have contracted COVID-19, gastrointestinal (GI) tract symptoms may remain for up to 2 years, as reported in a large retrospective study.

COVID-19 may leave lingering GI issues in children

10 Mar 2025

Children with post-COVID syndrome carry socio-educational burden

10 Mar 2025 by

Paediatric post-COVID syndrome (pPCS) brings a substantial socio-educational burden that must be included in medical, social, and educational care, suggests a study.

Children with post-COVID syndrome carry socio-educational burden

10 Mar 2025

Original New Drug Application Approvals by US FDA (1-15 February 2025)

10 Mar 2025

New drug applications approved by US FDA as of 1-15 February 2025 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Original New Drug Application Approvals by US FDA (1-15 February 2025)

10 Mar 2025

High-dose sulbactam tied to greater Cmid, PK-PD achievement

07 Mar 2025

Treatment with high-dose sulbactam leads to higher mid-dosing (Cmid) and pharmacokinetic-pharmacodynamic (PK-PD) achievement in paediatric patients, reports a study.

High-dose sulbactam tied to greater Cmid, PK-PD achievement

07 Mar 2025

News & Updates

Filter by Specialty:

Specialty:

Lebrikizumab improves anxiety, depression symptoms in adolescents with AD

Lebrikizumab improves anxiety, depression symptoms in adolescents with AD

Children with food allergies at risk of stunting, but immunotherapy helps

Children with food allergies at risk of stunting, but immunotherapy helps

Could early formula feeding be promoting infant food allergies?

Could early formula feeding be promoting infant food allergies?

Ruxolitinib cream shows benefit in patients with AD regardless of age

Ruxolitinib cream shows benefit in patients with AD regardless of age

Original New Drug Application Approvals by US FDA (16-28 February 2025)

Original New Drug Application Approvals by US FDA (16-28 February 2025)

SG sees drop in paediatric pneumococcal disease burden

SG sees drop in paediatric pneumococcal disease burden

COVID-19 may leave lingering GI issues in children

COVID-19 may leave lingering GI issues in children

Children with post-COVID syndrome carry socio-educational burden

Children with post-COVID syndrome carry socio-educational burden

Original New Drug Application Approvals by US FDA (1-15 February 2025)

Original New Drug Application Approvals by US FDA (1-15 February 2025)

High-dose sulbactam tied to greater Cmid, PK-PD achievement

High-dose sulbactam tied to greater Cmid, PK-PD achievement